Omnicell (OMCL) Tops Q1 EPS by 12c ; Offers Guidance

Omnicell (NASDAQ: OMCL) reported Q1 EPS of $0.03, $0.12 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $246.15 million versus the consensus estimate of $236.77 million.

GUIDANCE:

Omnicell sees Q2 2024 EPS of $0.10-$0.20, versus the consensus of $0.27. Omnicell sees Q2 2024 revenue of $250-260 million, versus the consensus of $261.9 million.

Omnicell sees FY2024 EPS of $0.90-$1.40, versus the consensus of $1.07. Omnicell sees FY2024 revenue of $1.05-1.12 billion, versus the consensus of $1.06 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c